Core Viewpoint - The company, DaAn Gene, has obtained a medical device registration certificate from the National Medical Products Administration for an HIV-1 DNA testing kit, indicating a significant advancement in its product offerings and potential market impact [1]. Company Summary - The medical device is named "HIV-1 DNA Test Kit (PCR-Fluorescent Probe Method)" and has been assigned the registration number 20253401805 [1]. - The certificate is valid from the date of approval until September 4, 2030, which suggests a long-term regulatory compliance for the product [1]. - The intended use of the product is for the qualitative detection of HIV-1 DNA in human whole blood samples, specifically targeting the M group [1]. Industry Summary - The approval of this testing kit aligns with the growing demand for reliable diagnostic tools in the healthcare sector, particularly for infectious diseases like HIV [1]. - The introduction of advanced testing methods may enhance the overall capabilities of the industry in managing and diagnosing HIV infections [1].
达安基因(002030.SZ):取得一个医疗器械注册证